Mustard gas exposure and carcinogenesis of lung

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 1, 2009, Pages 1-6

  Hosseini khalili, Alireza ^a,b   Haines, David D ^a   Modirian, Ehsan ^b   Soroush, Mohammadreza ^b   Khateri, Shahriar ^b   Joshi, Rashmi ^a   Zendehdel, Kazem ^c   Ghanei, Mostafa ^d   Giardina, Charles ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Iran; Lung; Mustard gas; p53

Indexed keywords

DNA; MUSTARD GAS; PROTEIN P53;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG SMALL CELL CANCER; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WAR;

ADULT; AGED; CHEMICAL WARFARE AGENTS; GENES, P53; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSTARD GAS; MUTATION;

EID: 68349131729     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.022     Document Type: Article

References (41)

1. Constanc M., and Pechura D.P.R. Veterans at Risk: Health Effects of Mustard Gas and Lewisite (1993), National Academic Press, Washington, DC pp. 218-221
2. United Nations Security Council. Report of Specialists Appointed by the Secretary General to investigate Allegations by the Islamic Republic of Iran Concerning the Use of Chemical Weapons (1986), United Nations Security Council Publication, New York, NY (S/16433/1986)
3. Emad A., and Rezaeian G.R. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single exposure: analysis of 197 cases. Chest 112 (1997) 734-738
4. Ghanei M., Adibi I., Farhat F., and Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?. Chron. Respir. Dis. 5 2 (2008) 95-100
5. Khateri S., Ghanei M., Keshavarz S., Soroush M.R., and Hains D. Incidence of lung, eye and skin lesions on late complications in 34,000 Iranian with wartime exposure to mustard agent. J. Occup. Environ. Med. 45 (2003) 1136-1143
6. Asensi V., et al. In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect. Immun. 72 7 (2004) 3823-3898
7. Savill J., and Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin. Cell Biol. 6 (1995) 385-393
8. International Agency for Research on Cancer (IARC). Monograph: Overall Evaluations of Carcinogenicity to Humans. 2004. Available at: http://www-cie.iarc.fr/monoeval/crthall.html. Accessed 30 January 2006.
9. Hemminki K., et al. DNA adducts, mutations, and cancer 2000. Regul. Toxicol. Pharmacol. 32 3 (2000) 264-275
10. Shibata M.A., et al. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea. Carcinogenesis 15 12 (1994) 2965-2968
11. Takeshima Y., Inai K., Bennett W.P., et al. p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis 15 10 (1994) 2075-2079
12. Adachi S., and Takemoto K. Occupational lung cancer. A comparison between humans and experimental animals. Sangyo Igaku 29 5 (1987) 345-357
13. Yamakido M., et al. Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. Environ. Health Perspect. 104 Suppl. 3 (1996) 485-488
14. Wada S., Nishimoto Y., Miyanishi M., Katsuta S., and Nishiki M. Malignant respiratory tract neoplasms related to poison gas exposure. Hiroshima J. Med. Sci. 11 (1962) 81-91
15. Weiss A., and Weiss B. Carcinogenesis due to mustard gas exposure in man, important sign for therapy with alkylating agents. Dtsch. Med. Wochenschr. 100 17 (1975) 919-923
16. Yamakido M., Ishioka S., Hiyama K., and Maeda A. Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. Environ. Health Perspect. 104 (May) (1996) 485-488
17. Easton D.F., Peto J., and Doll R. Cancers of the respiratory tract in mustard gas workers. Br. J. Ind. Med. 45 10 (1988) 652-659
18. Case R.A.M., and Lea A.J. Mustard gas poisoning, chronic bronchitis and lung cancer. An investigation into the possibility that poisoning by mustard gas in the 1914-1918 war might be a factor in the production of neoplasia. Br. J. Prev. Soc. Med. 9 (1955) 62-72
19. Beebe G.W. Lung cancer in World War I veterans. Possible relation to mustard gas injury and 1918 influenza epidemic. J. Natl. Cancer Inst. 25 (1960) 1231-1252
20. Norman Jr. J. Lung Cancer mortality in World War I veterans with mustard gas exposure (1919-1965). J. Natl. Cancer Inst. 54 2 (1975) 311-317
21. Bullman M.A., and Kang P.H. A fifty-year mortality follow-up study of veterans exposed to low-level chemical warfare agent, mustard gas. Ann. Epidemiol. 10 (2000) 333-338
22. Agency for Toxic Substances Disease Registry (ATSDR). Toxicological Profile for Sulfur Mustard (Update) Atlanta, GA (2003), U.S. Department of Health and Human Services, Public Health Service
23. Hsu S.M., Raine L., and Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75 (1981) 734-738
24. O'Rourke M.A., Feussner J.R., Feigl P., and Laszlo J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. JAMA 258 7 (1987) 921-926
25. Baas I.O., van den Berg F.M., Mulder J.W., Clement M.J., et al. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J. Pathol. 178 3 (1996) 264-267
26. Yamada Y., and Oghiso Y. Mutations in Tp53 gene sequences from lung tumors in rats that inhaled plutonium dioxide. Radiat. Res. 152 Suppl. 6 (December) (1999) S107-S109
27. Sadjadi A., Malekzadeh R., Derakhshan M.H., et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int. J. Cancer 107 1 (2003) 113-118
28. Hofseth L.J., Hussain S.P., and Harris C.C. p53: 25 years after its discovery. Trends Pharmacol. Sci. 25 4 (2004) 177-181
29. Wang W., and El-Deiry W.S. Restoration of p53 to limit tumor growth. Curr. Opin. Oncol. 20 1 (2008) 90-96
30. Bennett W.P., Hussain S.P., Vahakangas K.H., Khan M.A., Shields P.G., and Harris C.C. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J. Pathol. 187 1 (1999) 8-18
31. Rengul C.A., and Mehmet O. p53 mutations as fingerprints of environmental carcinogens. Pure Appl. Chem. 72 6 (2000) 995-999
32. Kishimoto Y., Murakami Y., Shiraishi M., Hayashi K., and Sekiya T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res. 52 17 (1992) 4799-4804
33. Miller C.W., Simon K., Aslo A., Kok K., Yokota J., Buys C.H., Terada M., and Koeffler H.P. p53 mutations in human lung tumors. Cancer Res. 52 7 (1992) 1695-1698
34. Nakachi K., Harris C.C., and Tahara E. Japan-US Cooperative Cancer Research Seminar on molecular epidemiological characteristics of lung and colon cancer development among atomic-bomb survivors, Bethesda, USA, 23-24 February 2006. Cancer Sci. 97 11 (2006) 1279-1282
35. Hayes R.B., Sheffet A., and Spirtas R. Cancer mortality among a cohort of chromium pigment workers. Am. J. Ind. Med. 16 (1989) 127-133
36. Kondo K., Hino N., Sasa M., Kamamura Y., Sakiyama S., Tsuyuguchi M., Hashimoto M., Uyama T., and Monden Y. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem. Biophys. Res. Commun. 239 1 (October 9) (1997) 95-100
37. Suzuki H., Takahashi T., Kuroishi T., et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 52 3 (1992) 734-736
38. Takahashi T., Takahashi T., Suzuki H., et al. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6 10 (1991) 1775-1778
39. Ehrlich M., Zhang X.Y., and Inamdar N.M. Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues. Mutat. Res. 238 3 (1990) 277-286
40. Pfeifer G.P. Mutagenesis at methylated CpG sequences. Curr. Top. Microbiol. Immunol. 301 (2006) 259-281
41. M.R. Zafarghandi, M.R. Soroush, M. Mahmoodi, K. Holakoui, A. Ardalan, A. Dolatyari, A. Abbasi, Surveillance Health Analysis of Mustard Chemical Exposure (SHALAMCHE) Study: Design and Methods (Unpublished report).